2004 Annual General Meeting & Conference

2004 Wed. 29 Sept

Session 1: Information agenda

Chair: Professor Mike Richards, National Cancer Director

09.45: Cancer information for public health and clinical governance
Sir Liam Donaldson, Chief Medical Officer 

10.15: The NHS National Programme for Information Technology - the potential for the Secondary Uses Service 
Mr Jeremy Thorp, Technical Director, NHS Information Authority

10.45: Cancer epidemiology and prevention: opportunities, priorities and barriers to progress 
Professor Julian Peto, London School of Hygiene & Tropical
Medicine and Institute of Cancer Research

Session 2


Chair: Professor David Forman, Director of Information and Research, Northern & Yorkshire Cancer Registry and Information Service

11.45: Natural history of prostate cancer - the Transatlantic Study 
Professor Jack Cuzick, Department of Epidemiology, Mathematics and Statistics, The Wolfson Institute of Preventative Medicine

12.15: Cancer information and health service regulation 
Dr Jenifer Smith, Consultant in Public Health/ Deputy Director of Public Health, Hampshire and Isle of Wight Strategic Health Authority and Specialist Advisor to the Healthcare Commission

Session 3: Public health

Chair: Dr Monica Roche, Medical Director of the Oxford Cancer Intelligence Unit and the South-East (West) Breast Screening Quality Assurance Reference Centre

13.45: Developing a patient information leaflet about the national cancer registration scheme

Dr Monica Roche, Medical Director, Oxford Cancer Intelligence Unit

14.00: New general practice contract. Opportunities for cancer registration
Dr Anna Gavin, Director, Northern Ireland Cancer Registry

14.15: Prognostic practice for survival in poor and affluent areas (NV42)
Dr Jasmina Stefoski Mikeljevic, Research Fellow, Northern & Yorkshire Cancer Registry and Information Service

14.30: Developing a protocol to handle cancer “cluster”
Ms Christine Harling, Head of Information, South West Cancer Intelligence Service

14.45: How is place of death for cancer patients changing and what affects it? An analysis of registry data for South East England 1985-2001
Dr Elizabeth Davies, Senior Lecturer in Cancer
Registration, Thames Cancer Registry

Session 4: Cancer services research

Chair: Dr David Brewster, Director, Scottish Cancer Registry

15.30: Extending quality assurance to all breast cancers: The BCCOM project
Dr Gill Lawrence, Director, West Midlands Cancer Intelligence Unit

15.45: Assessing the effect of clinical guidelines on cancer services for colorectal cancer

Dr Lou Gonsalves, Associate Director of Research and Information, West Midlands Cancer Intelligence Unit

16.00: Management of vulval cancer services in South West England 
Dr Jenny Weeks, Audit Project Manager, South West Cancer Intelligence Service

16.15: Waiting times for radiotherapy: variation over time and between cancer networks in South East England 
Mr David Robinson, Statistician, Thames Cancer Registry

2004 Thurs. 30 Sept

Session 5: Cancer registration and informatics

Chair: Mr Chris Carrigan, Cancer Registration Coordinator, Cancer Action Team

09.30: How useful is the Cancer Waiting Times (CWT) dataset for the purposes of cancer registration?
Mrs Caroline Brook, Information Services Manager, Northern & Yorkshire Cancer Registry and Information Service

09.45: Evaluation of electronic radiotherapy data for quality check on cancer registry data
Mr Colin Fox, IT Manager, Northern Ireland Cancer Registry

10.00: Development of cancer information workforce education and training strategy
Mrs Karin Lowson, Director, NHS Consulting, York Health Economics Consortium

10.30: Collecting the national cancer registration data set (NCRDS): A report on the NHSIA Pilot
Mr Nigel Brook, General Manager, Thames Cancer Registry

Session 6: Epidemiology

Chair: Dr Mike Quinn, Director, National Cancer Intelligence Centre, Office for National Statistics

11.15: Childhood leukaemia in Great Britain : trends in incidence, survival and ‘cure'
Ms Anjali Shah, PhD Student, London School of Hygiene & Tropical Medicine

11.30: Bladder cancer: later stage and worse survival in women from deprived areas
Dr Tony Moran, Director, North Western Cancer Registry

11.45: Obesity and smoking in patients with Barrett's oesophagus or adenocarcinoma of the oesophagus or gastro-oesophageal junction. Preliminary results from the Finbar study
Miss Lesley Anderson, Research Assistant, Northern Ireland Cancer Registry

12.00: A revolution in cancer care? Recent cancer mortality trends and the 12% target
Professor Henrik Møller, Director, Thames Cancer Registry

12.15: Is the rate of biological ageing, as measured by age at diagnosis of cancer, socio-economically patterned? An analysis of routinely collected data from a cancer registry
Dr Jean Adams, BUPA/Faculty of Public Health Medicine Research Fellow,University of Newcastle upon Tyne

12.30: Poster Prizes - Dr Mike Quinn

Session 7: International collaborations

Chair: Professor Henrik Møller, Director, Thames Cancer Registry

13.45: Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening
Mr Freddie Bray, Technical Officer, International Agency for Research on Cancer

14.00: Comparison of survival following colorectal cancer in England, Scotland and the Nordic countries using period survival analysis
Ms Gerda Engholm, Senior Statistician, Danish Cancer Society

14.15: Cancer trends and the impact of medical interventions: data from the Italian Network of Cancer Registries (AIRT)
Dr Eugenio Paci, Director, Tuscany Region Cancer Registry

14.30: Relative survival for twenty common adult cancers in the UK and the Republic of Ireland
Dr Bernard Rachet, Clinical Lecturer, London School of Hygiene & Tropical Medicine

14.45: The EUROCADET study
Dr Jan Willem Coebergh, Director, Eindhoven Cancer Registry

Wednesday, September 29, 2004 to Thursday, September 30, 2004
The Thistle Tower Hotel
St. Katharine's Way
United Kingdom